Route 92 Medical Announces Commercial Launch of FreeClimb 88 Catheter System
22. Juli 2024 08:00 ET
|
Route 92 Medical, Inc.
Route 92 Medical announces the commercial launch of its FreeClimb 88 catheter system.
Route 92 Medical Announces FDA 510(k) Clearance for FreeClimb 54 Reperfusion System
30. April 2024 08:00 ET
|
Route 92 Medical, Inc.
Route 92 Medical announces FDA 510(k) clearance for its FreeClimb 54 reperfusion system, part of its growing portfolio of neurovascular devices.
GNT Pharma Provides Update on Two Phase III Studies of Nelonemdaz for Acute Ischemic Stroke Patients Treated with tPA (ENIS-3) or Endovascular Thrombectomy (RODIN)
19. September 2022 09:00 ET
|
GNT Pharma Co., Ltd
Promising efficacy and safety profiles were observed in prior Phase II studies in acute ischemic stroke patients treated with recanalization therapies. The ENIS-3 trial has achieved >33% of...
GNT Pharma Announces Approval of IND Application for the Phase III RODIN Trial of Nelonemdaz for Acute Ischemic Stroke Patients
08. September 2021 06:00 ET
|
GNT Pharma Co., Ltd
PIII Study for 496 ischemic stroke patients treated with endovascular thrombectomyFirst multi-target neuroprotectant for the intervention of ischemic brain injurySafety and efficacy verified in two...